Innoviva, Inc. Uncategorized Contracts & Agreements

33 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Offer Letter between Innoviva, Inc. and Stephen Basso, dated July 28, 2023
Innoviva, Inc.
Pharmaceuticals
DE
2023
Support Agreement, dated July 10, 2022, by and among Innoviva, Inc., Innoviva Acquisition Sub, Inc., Tang Capital Partners, LP and the Kevin C. Tang Foundation
Innoviva, Inc.
Pharmaceuticals
2022
Offer Letter between Innoviva, Inc. and Pavel Raifeld, dated April 29, 2022
Innoviva, Inc.
Pharmaceuticals
2022
Form of Capped Call Confirmation
Innoviva, Inc.
Pharmaceuticals
2022
ISP FUND LP c/o Sarissa Capital Fund GP LP 660 Steamboat Road, 3rd Floor Greenwich, Connecticut 06830
Innoviva, Inc.
Pharmaceuticals
2021
Offer Letter between Innoviva, Inc. and Pavel Raifeld, dated May 20, 2020
Innoviva, Inc.
Pharmaceuticals
2020
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Innoviva, Inc.
Pharmaceuticals
2020
Agreement between Innoviva, Inc. and Marianne Zhen dated as of September 7, 2018
Innoviva, Inc.
Pharmaceuticals
2018
Offer Letter with Geoffrey Hulme dated as of May 18, 2018
Innoviva, Inc.
Pharmaceuticals
CA
2018
Agreement, dated as of February 12, 2018, by and among Innoviva, Inc., Sarissa Capital Domestic Fund LP, and certain of its affiliates
Innoviva, Inc.
Pharmaceuticals
DE
2018
Agreement between Innoviva, Inc. and Eric dEsparbes dated as of February 7, 2018
Innoviva, Inc.
Pharmaceuticals
2018
Relocation Assistance For Michael E. Faerm
Innoviva, Inc.
Pharmaceuticals
2016
Relocation Assistance For Eric dEsparbes
Innoviva, Inc.
Pharmaceuticals
2015
EXHIBIT A Adjustments to Your Theravance Equity Awards in Connection with the Spin-Off
Innoviva, Inc.
Pharmaceuticals
2014
EMPLOYEE MATTERS AGREEMENT by and between THERAVANCE, INC. and THERAVANCE BIOPHARMA, INC. Dated as of June 1, 2014
Innoviva, Inc.
Pharmaceuticals
DE
2014
TAX MATTERS AGREEMENT by and between THERAVANCE, INC. and THERAVANCE BIOPHARMA, INC. Dated as of June 2, 2014
Innoviva, Inc.
Pharmaceuticals
DE
2014
ANNEX A RULES OF CONSTRUCTION AND DEFINED TERMS
Innoviva, Inc.
Pharmaceuticals
DE
2014
ACCOUNT CONTROL AGREEMENT
Innoviva, Inc.
Pharmaceuticals
NY
2014
THERAVANCE STRATEGIC ALLIANCE AGREEMENT AMENDMENT
Innoviva, Inc.
Pharmaceuticals
DE
2014
MASTER AGREEMENT
Innoviva, Inc.
Pharmaceuticals
DE
2014
COMMERCIALIZATION AGREEMENT by and between THERAVANCE, INC. and CLINIGEN GROUP PLC Dated: March 8, 2013
Innoviva, Inc.
Pharmaceuticals
NY
2013
THERAVANCE, INC. December , 2010
Innoviva, Inc.
Pharmaceuticals
2011
Theravance, Inc. CashBonus Program, amended effective as of February 10, 2010
Innoviva, Inc.
Pharmaceuticals
2010
THERAVANCE, INC. 2008 NEW EMPLOYEE EQUITYINCENTIVE PLAN (AS ADOPTED EFFECTIVEJANUARY 29, 2008) (AS AMENDED JULY 21, 2009)
Innoviva, Inc.
Pharmaceuticals
2009
CONSULTINGAGREEMENT
Innoviva, Inc.
Pharmaceuticals
CA
2008
AMENDMENT TO AMENDED AND RESTATED RIGHTS AGREEMENT
Innoviva, Inc.
Pharmaceuticals
2008
CONSULTINGAGREEMENT
Innoviva, Inc.
Pharmaceuticals
CA
2008
FIRSTADDENDUM TO THE TERMS & CONDITIONS DATED FEBRUARY 17, 2004 THERAVANCE, INC. AND BEN VENUELABORATORIES, INC.
Innoviva, Inc.
Pharmaceuticals
OH
2007
THERAVANCE, INC. 2004 EQUITYINCENTIVE PLAN NOTICE OFSTOCK OPTION GRANT
Innoviva, Inc.
Pharmaceuticals
DE
2007
Theravance,Inc. CashBonus Program, amended effective as of February 28, 2007
Innoviva, Inc.
Pharmaceuticals
2007
SHARES
Innoviva, Inc.
Pharmaceuticals
2007
AMENDMENT TO LICENSE,DEVELOPMENT AND COMMERCIALIZATIONAGREEMENT
Innoviva, Inc.
Pharmaceuticals
2006
CONSULTINGAGREEMENT
Innoviva, Inc.
Pharmaceuticals
CA
2005